Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Capital Expenditures: 2024-2025

Historic Capital Expenditures for Zenas BioPharma (ZBIO) over the last 1 years, with Mar 2025 value amounting to $18,000.

  • Zenas BioPharma's Capital Expenditures fell 18.18% to $18,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $149,000, marking a year-over-year change of. This contributed to the annual value of $131,000 for FY2024, which is 670.59% up from last year.
  • According to the latest figures from Q1 2025, Zenas BioPharma's Capital Expenditures is $18,000, which was down 75.68% from $74,000 recorded in Q4 2024.
  • Zenas BioPharma's 5-year Capital Expenditures high stood at $74,000 for Q4 2024, and its period low was $18,000 during Q1 2025.
  • For the 2-year period, Zenas BioPharma's Capital Expenditures averaged around $37,250, with its median value being $28,500 (2024).
  • Data for Zenas BioPharma's Capital Expenditures shows a maximum YoY declined of 18.18% (in 2025) over the last 5 years.
  • Zenas BioPharma's Capital Expenditures (Quarterly) stood at $74,000 in 2024, then dropped by 18.18% to $18,000 in 2025.
  • Its last three reported values are $18,000 in Q1 2025, $74,000 for Q4 2024, and $35,000 during Q2 2024.